The Placebo Effect Mechanisms and Methodology (R21) | Apply Online

Opportunity Summary:

The funding opportunity titled "The Placebo Effect Mechanisms and Methodology (R21)" (Funding Opportunity Number RFA-DA-12-004) is a discretionary National Institutes of Health (NIH) grant program designed to support early-stage, exploratory research on placebo effects. It uses the NIH Exploratory/Developmental Research Grant Award (R21) mechanism, which is typically intended for innovative projects that may be higher risk but have the potential to open up new lines of investigation. The central purpose of this announcement is to encourage studies that clarify the biological pathways and processes that produce placebo effects, while also improving the tools and methods researchers use to identify, measure, and potentially harness placebo-related therapeutic benefits in both clinical trials and real-world clinical care.

At its core, the FOA is aimed at moving placebo research beyond the idea of placebo as simply a nuisance variable in trials and toward a clearer, biologically grounded understanding of how expectancy, learning, context, and patient-provider interactions translate into measurable changes in symptoms and physiology. Projects responsive to this call would generally focus on mechanisms (for example, neurobiological, psychophysiological, genetic, endocrine, immune, or other systems-level pathways) and/or methodology (for example, trial designs, measurement strategies, biomarkers, or analytical approaches) that can reliably distinguish placebo responses from other influences such as natural disease variation, regression to the mean, reporting bias, or non-specific treatment effects. Another implied goal is practical: improving clinical research and practice by learning how to recognize when placebo mechanisms are likely to be operating and how their beneficial components might be ethically enhanced without compromising scientific rigor or patient trust.

This opportunity is sponsored by the NIH and is categorized under the broad activity areas of education and health. It is associated with multiple CFDA program areas, including 93.213 (Research and Training in Complementary and Integrative Health), 93.273 (Alcohol Research Programs), and 93.279 (Drug Abuse and Addiction Research Programs). Those CFDA linkages signal that NIH was explicitly interested in placebo mechanisms as they relate to a range of conditions and research domains, including but not limited to substance use and addiction research, alcohol-related research, and complementary/integrative health contexts where expectancy and contextual healing factors often play a significant role. The funding instrument is a grant, and there is no cost sharing or matching requirement, which reduces the administrative and financial burden on applicants.

Eligibility for this FOA is notably broad, reflecting NIH's interest in bringing in diverse perspectives and capabilities. Eligible applicants include public and state-controlled institutions of higher education, private institutions of higher education, nonprofit organizations both with and without 501(c)(3) status, for-profit organizations other than small businesses, and small businesses. In addition, a wide range of government entities are eligible, including state governments, county governments, city or township governments, special district governments, and independent school districts, as well as public housing authorities and Indian housing authorities. The announcement also explicitly includes Native American tribal governments (federally recognized) and Native American tribal organizations (other than federally recognized tribal governments), and it expands eligibility to a number of institution types and community-based entities such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, tribally controlled colleges and universities (TCCUs), Alaska Native and Native Hawaiian-serving institutions, and faith-based or community-based organizations. It further allows non-U.S. entities (foreign organizations), regional organizations, eligible federal agencies, and U.S. territories or possessions, which underscores NIH's openness to international or cross-jurisdictional expertise where appropriate.

From an administrative standpoint, the announcement was posted and created on February 17, 2011, with an original and current closing date of May 24, 2011, and it was archived on June 24, 2011. The full announcement was made available through the NIH grants guide at the provided URL (http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-12-004.html). For access or technical issues, NIH directed applicants to contact the NIH Office of Extramural Research (OER) webmaster via the listed email addresses, indicating that the primary support contact in the source data is geared toward resolving announcement access and linking problems rather than scientific program questions.

In practical terms, a strong application under this FOA would have been expected to propose a clearly defined exploratory study that either illuminates how placebo effects are generated biologically (for example, identifying pathways and measurable signals associated with expectancy-driven symptom relief) or advances the research methods used to study placebo effects (for example, improving how placebo responses are detected, quantified, or separated from confounding factors in trial settings). Because the R21 mechanism is designed for developmental work, the emphasis would typically be on innovation and feasibility, with the expectation that successful R21 projects could set the stage for larger, more definitive studies later.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education Health

Next opportunity: The Placebo Effect Mechanisms and Methodology (R01)

Previous opportunity: Office of Innovation and Improvement (OII) Professional Development for Arts Educators (PDAE) Program CFDA Number 84.351C

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA DA 12 004

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (RFA DA 12 004) also looked into and applied for these:

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA DA 12 004", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.